Bli medlem
Bli medlem

Du är här

2015-04-23

Biotie Therapies Oyj: Change in the number of votes relating to Biotie Therapies Corp.'s shares

Biotie Therapies Corp. Stock Exchange Release 23 April 2015 at
10.25 a.m.

Change in the number of votes relating to Biotie Therapies Corp.'s shares

The Swiss subsidiary of Biotie Therapies Corp. ("Biotie" or the "Company"),
Biotie Therapies AG (previously Synosia Therapeutics Holding AG and Biotie
Therapies Holding AG) has conveyed Biotie shares against consideration
pursuant to the option programs as follows:

-----------------------------------------------------
| April 2015 to date Total (5/2011- Options |
| |
| 4/2015 to date) outstanding |
| 84,344 9,660,116 2,740,428 |
-----------------------------------------------------
The conveyance of Biotie shares relates to the option plan of Synosia
Therapeutics Holding AG (currently Biotie Therapies Holding AG, "Synosia")
acquired by Biotie in February 2011. According to such Synosia share option
plan, options have been granted to employees, former directors and
consultants. In connection with the completion of the acquisition of Synosia,
the option plan was amended so that instead of shares in Synosia an aggregate
maximum of 14,912,155 shares in Biotie may be subscribed based on the plan.
Biotie issued these 14,912,155 shares to its current subsidiary Synosia in
connection with the acquisition to be further conveyed to the option holders
when they potentially exercise their option rights in accordance with the
terms and conditions of the option program.

The conveyed shares previously held as Treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered
shares.

After the conveyances the changes are as follows:

-------------------------------------------------------------------------------------------------
| Increase in number of outstanding shares Total amount of Number of the Total number |
| |
| voting rights Company's share held of registered |
| by the Biotie Group shares |
| 84,344 452,357,234 3,610,940 455,968,174 |
-------------------------------------------------------------------------------------------------
Turku, 23 April 2015

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:

Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi@biotie.com

DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire

HUG#1913805

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.